Skip to content

Physical Exam Indicated Cerclage in Singleton Gestation 24 Weeks to 25 Weeks and 6 Days Gestation

Randomized Controlled Trial: Physical Exam Indicated Cerclage in Singleton Gestation 24 Weeks to 25 Weeks and 6 Days Gestation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05501938
Enrollment
30
Registered
2022-08-16
Start date
2022-08-11
Completion date
2023-08-11
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Brief summary

RCT assessing preterm delivery rate in singleton pregnancies having a physical-exam indicated cerclage placed between 24 weeks and 25 weeks and 6 days. Patients randomized to either cerclage intervention or routine standard of care (no cerclage).

Interventions

Transvaginal cervical cerclage

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Intervention (cerclage) and control (no-cerclage) to reduce/prevent preterm delivery in those with a dilated cervix between 24w0d and 25w6d

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Pregnant women 18 years of age or older 2. Nulliparous patient, has not had a preterm to term delivery 3. Singleton pregnancy 4. English or Spanish speaking 5. Asymptomatic cervical dilation between 1- 2 cm, without visible membranes beyond the external cervical os and without any evidence of infection, active labor or active bleeding between 24 0/7 and 25 6/7 weeks gestation

Exclusion criteria

1. Twin or higher order multi-fetal gestation 2. Multiparous patient, has had one or more preterm to term deliveries 3. Cervical dilation more than 2 cm either at the beginning of the study or any time during the study 4. Amniotic membranes prolapsed beyond the external os 5. Fetal reduction procedure performed during current pregnancy 6. Ruptured membranes prior to randomization 7. Major fetal structural anomaly 8. Fetal chromosomal abnormality, suspected or confirmed with additional genetic testing 9. Cerclage already in place for other indication 10. Active vaginal bleeding 11. Suspicion of chorioamnionitis 12. Placenta previa 13. Painful regular uterine contractions 14. History of preterm birth before 37 weeks gestation 15. Non-English or non-Spanish speaking a. Given that the study is explained in person and consent forms are written in English, there is no guarantee that the study will be explained correctly when using a phone translator. The same is true if the current English consent form were to be translated into a language other than English. There is no way to confirm that the integrity of the study is being upheld by using translating services. If the integrity of the study is not upheld, then this poses harm to the patient. 16. Women under 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Preterm Delivery Rate1 YearCompare preterm delivery rate between women receiving cerclage intervention between 24w0d and 25w6d vs those not receiving cerclage during this gestational age period

Secondary

MeasureTime frameDescription
Neonatal Outcomes1 YearRate of neonatal outcomes compared between the two groups ( NICU length of stay, neonatal death, neonatal disease (bronchopulmonary dysplasia, Necrotizing enterocolitis, Intraventricular hemorrhage, Respiratory distress syndrome, Retinopathy of prematurity, sepsis, death)

Other

MeasureTime frameDescription
Cerclage Surgical Complications1 yearRate of cerclage complications (intra-operative PPROM, hemorrhage, need for blood transfusion, cervical or vaginal laceration

Countries

United States

Contacts

Primary ContactCraig Zelig, MD
zeligc@amc.edu9105464305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026